Roche Holding Ltd. Genussscheine (VTX:ROG) Given a CHF 320 Price Target by Goldman Sachs Group Analysts
Goldman Sachs Group set a CHF 320 target price on Roche Holding Ltd. Genussscheine (VTX:ROG) in a research report sent to investors on Wednesday, Borsen Zeitung reports. The firm currently has a buy rating on the healthcare company’s stock.
Several other research analysts also recently weighed in on ROG. Kepler Capital Markets set a €46.00 ($53.49) target price on Deutsche Wohnen and gave the stock a buy rating in a research note on Tuesday, April 23rd. Barclays boosted their target price on Intuit from $225.00 to $237.00 and gave the stock an equal weight rating in a research note on Friday, May 24th. Credit Suisse Group set a €50.00 ($58.14) target price on Unilever and gave the stock a neutral rating in a research note on Thursday, April 18th. Morgan Stanley restated an equal weight rating and set a GBX 250 ($3.27) target price on shares of BT Group in a research note on Tuesday, April 30th. Finally, Jefferies Financial Group boosted their price target on IAC/InterActiveCorp from $260.00 to $270.00 and gave the company a buy rating in a research note on Thursday, April 18th. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and ten have issued a buy rating to the company. The company presently has a consensus rating of Hold and a consensus target price of CHF 280.19.
Roche Holding Ltd. Genussscheine has a one year low of CHF 214.30 and a one year high of CHF 273.
Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide. The company's Advanced Connectivity Solutions segment offers circuit materials and solutions for connectivity applications in wireless communications infrastructure, automotive, connected devices, wired infrastructure, consumer electronics, and aerospace/defense.
Further Reading: The primary rules of Elliott Wave theory
Receive News & Ratings for Roche Holding Ltd. Genussscheine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. Genussscheine and related companies with MarketBeat.com's FREE daily email newsletter.